# Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock

> **NCT06169475** · NA · COMPLETED · sponsor: **Xinchen Wang** · enrollment: 14 (actual)

## Conditions studied

- Septic Shock
- Stress Response
- Cerebral Hemodynamics

## Interventions

- **DRUG:** Dexmedetomidine Hydrochloride
- **DRUG:** Esmolol Hydrochloride

## Key facts

- **NCT ID:** NCT06169475
- **Lead sponsor:** Xinchen Wang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2021-11-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06169475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06169475, "Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06169475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*